Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Insperity, Inc. and its officers or directors following disappointing financial results and a significant stock price drop [1][3]. Financial Performance - On August 1, 2025, Insperity reported adjusted earnings per share of $0.26 for Q2 2025, which was a 70% decline year-over-year and below analyst expectations [3]. - The company attributed the poor performance to higher-than-expected benefits costs, particularly due to rising pharmacy expenses and an increase in large insurance claims [3]. - Following the announcement, Insperity's stock price fell by $14.51, or 24.35%, closing at $45.07 per share on the same day [4]. Legal Investigation - Pomerantz LLP is actively seeking claims from investors of Insperity regarding potential securities fraud or other unlawful practices [1]. - The firm has a long history in corporate and securities class litigation, having recovered significant damages for victims of securities fraud and corporate misconduct [5].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Insperity, Inc. – NSP